Evidence map›Paper›PMID 28740233›Full record

ArticleScientific reports2017

A receptor dependent-4D QSAR approach to predict the activity of mutated enzymes.

R Pravin Kumar, Naveen Kulkarni

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Two Decades of 4D-QSAR: A Dying Art or Staging a Comeback?International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R Pravin KumarPolyclone Bioservices, #437, 40th Cross, Jayanagar 5th Block, Bangalore, 560041, India. pravinpaul2@gmail.com.
Naveen KulkarniPolyclone Bioservices, #437, 40th Cross, Jayanagar 5th Block, Bangalore, 560041, India.
Sri Jayadeva Institute of Cardiovascular Sciences and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening and selection tools to obtain focused libraries play a key role in successfully engineering enzymes of desired qualities. The quality of screening depends on efficient assays; however, a focused library generated with a priori information plays a major role in effectively identifying the right enzyme. As a proof of concept, for the first time, receptor dependent - 4D Quantitative Structure Activity Relationship (RD-4D-QSAR) has been implemented to predict kinetic properties of an enzyme. The novelty of this study is that the mutated enzymes also form a part of the training data set. The mutations were modeled in a serine protease and molecular dynamics simulations were conducted to derive enzyme-substrate (E-S) conformations. The E-S conformations were enclosed in a high resolution grid consisting of 156,250 grid points that stores interaction energies to generate QSAR models to predict the enzyme activity. The QSAR predictions showed similar results as reported in the kinetic studies with >80% specificity and >50% sensitivity revealing that the top ranked models unambiguously differentiated enzymes with high and low activity. The interaction energy descriptors of the best QSAR model were used to identify residues responsible for enzymatic activity and substrate specificity.

Indexed as

MutationQuantitative Structure-Activity RelationshipCrystallography, X-RayFactor XIaKineticsModels, MolecularMolecular Dynamics SimulationMutant ProteinsProtein ConformationSerine ProteasesSubstrate SpecificityFactor XIaMutant ProteinsSerine Proteases

Identifiers

PMID28740233
PMCPMC5524700
OpenAlexW2738304688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.